Save your place

Sign in to WhoBought

Please try again later.

Ray Dalio's Vertex Pharmaceuticals Incorporated (VRTX) position

Yes: as of Q1 2026, Ray Dalio holds 13K shares of VRTX worth $6.0M (0.0% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$6.0M
Shares held
13K
% of portfolio
0.0%
Est. average buy price (i)
$456.42
Quarter-end price
$446.54

Estimated trade prices

Average price in quarters with purchases
$297.07
Average prices in quarters with sales
  • Q1 2026: $466.52 (14K shares sold)
  • Q4 2025: $430.92 (11K shares sold)
  • Q4 2024: $463.53 (3K shares sold)
  • Q3 2024: $480.37 (30K shares sold)
  • Q2 2024: $434.05 (101K shares sold)
  • Q4 2023: $369.42 (26K shares sold)
  • Q3 2023: $349.73 (18K shares sold)
  • Q2 2023: $336.94 (28K shares sold)
  • Q4 2022: $304.77 (63K shares sold)
  • Q3 2022: $287.72 (53K shares sold)
  • Q4 2021: $194.45 (3K shares sold)
  • Q3 2021: $195.24 (8K shares sold)

VRTX price vs Dalio's position

1Y 3Y 5Y MAX
Dates
$100$200$400$60020222023202420252026Sold 8K shares (35.0%) · Q3 2021. Average closing price $195.24 · Price range $181.39–$202.998KsharessoldSold 3K shares (17.9%) · Q4 2021. Average closing price $194.45 · Price range $177.01–$223.453KsharessoldAdded 18K shares (142.8%) · Q1 2022. Average closing price $237.33 · Price range $221.42–$260.9718KsharespurchasedAdded 187K shares (620.2%) · Q2 2022. Average closing price $267.66 · Price range $234.96–$292.55187KsharespurchasedSold 53K shares (24.5%) · Q3 2022. Average closing price $287.72 · Price range $273.83–$305.5353KsharessoldSold 63K shares (38.5%) · Q4 2022. Average closing price $304.77 · Price range $285.76–$321.4863KsharessoldAdded 103K shares (102.6%) · Q1 2023. Average closing price $299.93 · Price range $283.23–$323.10103KsharespurchasedSold 28K shares (13.7%) · Q2 2023. Average closing price $336.94 · Price range $314.42–$351.9128KsharessoldSold 18K shares (10.2%) · Q3 2023. Average closing price $349.73 · Price range $338.18–$362.4618KsharessoldSold 26K shares (16.4%) · Q4 2023. Average closing price $369.42 · Price range $343.00–$410.6826KsharessoldAdded 2K shares (1.8%) · Q1 2024. Average closing price $422.74 · Price range $407.69–$446.082KsharespurchasedSold 101K shares (75.3%) · Q2 2024. Average closing price $434.05 · Price range $392.81–$485.53101KsharessoldSold 30K shares (89.6%) · Q3 2024. Average closing price $480.37 · Price range $460.00–$505.7830KsharessoldSold 3K shares (79.4%) · Q4 2024. Average closing price $463.53 · Price range $396.64–$516.743KsharessoldNew position of 34K shares · Q2 2025. Average closing price $460.83 · Price range $421.16–$509.5034KsharespurchasedAdded 4K shares (11.4%) · Q3 2025. Average closing price $417.89 · Price range $368.03–$479.534KsharespurchasedSold 11K shares (28.3%) · Q4 2025. Average closing price $430.92 · Price range $402.90–$463.1311KsharessoldSold 14K shares (51.4%) · Q1 2026. Average closing price $466.52 · Price range $433.07–$499.1714Ksharessold← Earlier —1 purchase
Average closing price · filing quarter
$466.52
Price range · filing quarter
$433.07 – $499.17
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −14K −$6.6M −51.4% 13K May 15, 2026
Q4 2025 Reduced −11K −$4.7M −28.3% 27K Feb 13, 2026
Q3 2025 Added +4K +$1.6M +11.4% 38K Nov 13, 2025
Q2 2025 New +34K +$16M – 34K Aug 13, 2025
Q4 2024 Reduced −3K −$1.3M −79.4% 710 Feb 13, 2025
Q3 2024 Reduced −30K −$14M −89.6% 3K Nov 13, 2024
Q2 2024 Reduced −101K −$44M −75.3% 33K Aug 14, 2024
Q1 2024 Added +2K +$990K +1.8% 135K May 14, 2024
Q4 2023 Reduced −26K −$9.6M −16.4% 132K Feb 14, 2024
Q3 2023 Reduced −18K −$6.3M −10.2% 158K Nov 13, 2023
Q2 2023 Reduced −28K −$9.4M −13.7% 176K Aug 11, 2023
Q1 2023 Added +103K +$31M +102.6% 204K May 12, 2023
Q4 2022 Reduced −63K −$19M −38.5% 101K Feb 13, 2023
Q3 2022 Reduced −53K −$15M −24.5% 164K Nov 10, 2022
Q2 2022 Added +187K +$50M +620.2% 217K Aug 11, 2022
Q1 2022 Added +18K +$4.2M +142.8% 30K May 13, 2022
Q4 2021 Reduced −3K −$525K −17.9% 12K Feb 14, 2022
Q3 2021 Reduced −8K −$1.6M −35.0% 15K Nov 12, 2021
Q2 2021 Added +2K +$328K +7.2% 23K Aug 13, 2021
Q1 2021 First covered – – – 22K May 14, 2021
Data through Q1 2026 · filed May 15, 2026
20 grouped rows from 20 quarters

More Dalio positions

Amazon.com, Inc.(AMZN)
$905M
4.1% of portfolio

NVIDIA Corporation(NVDA)
$812M
3.7% of portfolio

Alphabet Inc.(GOOGL)
$562M
2.6% of portfolio

Broadcom Inc.(AVGO)
$568M
2.5% of portfolio

Micron Technology, Inc.(MU)
$499M
2.2% of portfolio

Microsoft Corporation(MSFT)
$402M
1.8% of portfolio

Common questions

Does Ray Dalio own VRTX?

Yes. As of Q1 2026, Ray Dalio disclosed 13K shares of VRTX, worth $6.0M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ray Dalio buy VRTX?

Ray Dalio held VRTX since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ray Dalio sell VRTX?

The quarter-by-quarter table above shows each sale and reduction Ray Dalio disclosed in VRTX. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of VRTX does Ray Dalio own?

Ray Dalio disclosed 13K shares of VRTX as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ray Dalio pay for VRTX?

Ray Dalio's estimated average buy price for VRTX is $456.42, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.